難治性突発性難聴に対するウログラフィン<sup>®</sup>の効果の検討

DOI
  • 大森 英哉
    Department of Anesthesiology Kitami Redcross Hospital
  • 小林 巌
    Department of Anesthesiology Kitami Redcross Hospital
  • 高橋 広巳
    Department of Anesthesiology Kitami Redcross Hospital
  • 金井 直樹
    Department of Otorhinolaryngology Kitami Redcross Hospital
  • 岩崎 寛
    Department of Anesthesiology Sapporo Medical University, School of Medicine
  • 並木 昭義
    Department of Anesthesiology Sapporo Medical University, School of Medicine

書誌事項

タイトル別名
  • Recovery of Hearing with Amidotrizoate in Sudden Deafness

説明

We treated 23 patients with sudden hearling loss by intravenous administration of amidotrizoate (60% Urografin) after conventional therapy. The patients were initially treated with prednisolone, Vitamine B12, stellate ganglion block, and hyperbaric oxygen. Conventional therapy led to a partial recovery of hearing acuity and vertigo in 26.1% of the patients. However, there was no change in symptoms in the other patients. Twenty milliliters of amidotrizoate was intravenously administered every day for a week. Following treatment with amidotrizoate, a complete, marked, and partial recovery of symptoms was observed in 4.3%, 17.4%, and 34.8% of the patients, respectively. However, 43.5% of the patients showed no change in symptoms. No side effects were observed following amidotrizoate therapy. We conclude that intravenous administration of amidotrizoate may recover hearing in patients with sudden deafness.

収録刊行物

詳細情報 詳細情報について

  • CRID
    1390282679436504960
  • NII論文ID
    130004239192
  • DOI
    10.11321/jjspc1994.5.4_491
  • ISSN
    18841791
    13404903
  • データソース種別
    • JaLC
    • CiNii Articles
  • 抄録ライセンスフラグ
    使用不可

問題の指摘

ページトップへ